NHS drug suppliers investigated over prices

The Guardian, 26 October 2016
Source: Press Association
“The competition watchdog has launched an investigation into drug companies accused of charging the NHS excessive prices. The CMA said: “The investigation relates to suspected unfair pricing by way of charging excessive prices in the supply of certain pharmaceutical products, including to the National Health Service.” An investigation by the Times alleged that companies faced limited competition on long-established, off-patent drugs, bought from large pharmaceutical firms.”
Find article here.